Drug Trial Radar · NCT04537923
A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin
Last checked: Nov 20, 2026Latest source record: Nov 2, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,428
Actual
Start
Oct 19, 2020
Primary completion
Oct 11, 2022
Study completion Nov 1, 2022
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Sep 3, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the safety and efficacy of the study drug tirzepatide to insulin lispro (U100) three times a day in participants with type 2 diabetes that are already on insulin glargine (U100), with or without metformin.
Conditions
- Type 2 Diabetes
Interventions
TirzepatideDrug
Administered SC
Insulin Lispro (U100)Drug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Hemoglobin A1c (HbA1c) (Pooled Doses of Tirzepatide 5 mg, 10 mg and 15 mg)Time frame: Baseline, Week 52
Locations
135 sites in 16 countries. Site status is shown where the registry gives one.
Syed Research Consultants Llc
Sheffield, Alabama
Valley Research
Fresno, California
National Research Institute - Huntington Park
Huntington Park, California
National Research Institute - Huntington Park
Los Angeles, California
Valley Clinical Trials, Inc.
Northridge, California
National Research Institute - Huntington Park
Panorama City, California
National Research Institute (NRI) - Santa Ana
Santa Ana, California
Encompass Clinical Research
Spring Valley, California
University Clinical Investigators, Inc.
Tustin, California
University of Colorado
Aurora, Colorado
Excel Medical Clinical Trials
Boca Raton, Florida
I R & Health Center, Inc.
Hialeah, Florida
Sun Coast Clinical Research, Inc
New Port Richey, Florida
South Broward Research
Pembroke Pines, Florida
Metabolic Research Institute, Inc.
West Palm Beach, Florida
Rocky Mountain Clinical Research
Idaho Falls, Idaho
J H. Stroger Hosp of Cook Co
Chicago, Illinois
Prairie Education and Research Cooperative
Springfield, Illinois
Iowa Diabetes and Endocrinology Research Center
West Des Moines, Iowa
Capital Diabetes and Endocrine Associates
Camp Springs, Maryland
MedStar Health Research Institute
Hyattsville, Maryland
Endocrine and Metabolic Consultants
Rockville, Maryland
Glacier View Research Institute - Endocrinology
Kalispell, Montana
Southern Nh Diabetes and Endocrinology
Nashua, New Hampshire
Albany Medical College
Albany, New York
PMG Research of Wilmington
Wilmington, North Carolina
Intend Research, LLC
Norman, Oklahoma
Heritage Valley Medical Group, Inc.
Beaver, Pennsylvania
Preferred Primary Care Physicians
Uniontown, Pennsylvania
Tribe Clinical Research, LLC
Greenville, South Carolina
Dallas Diabetes Research Center
Dallas, Texas
Diabetes and Thyroid Center of Fort Worth
Fort Worth, Texas
Juno Research
Houston, Texas
Biopharma Informatic, LLC
Houston, Texas
North Hills Medical Research
North Richland Hills, Texas
Texas Diabetes & Endocrinology, P.A.
Round Rock, Texas
Clinical Trials of Texas, Inc.
San Antonio, Texas
Consano Clinical Research, LLC
Shavano Park, Texas
Martin Diagnostic Clinic
Tomball, Texas
Rainier Clinical Research Center
Renton, Washington
Showing 40 of 135 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.